Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg
To Evaluate the Increase of Local Circulation in the Leg Using the Flowaid Device
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This is an open label pilot study to evaluate the efficacy and the safety of the Flowaid device in increasing local circulation in the legs. 15 patients with a diagnosis of Peripheral Vascular Disease will be enrolled in this study. They will recieve tratment with the Flowaid device and monitored continuously by means of Laser Doppler Flowmetry as well as by tcPO2 and Digital Thermography. Subjective data will also be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2007
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2007
CompletedStudy Start
First participant enrolled
October 1, 2007
CompletedFirst Posted
Study publicly available on registry
October 2, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2007
CompletedMarch 4, 2008
March 1, 2008
September 29, 2007
March 3, 2008
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Give appropriate written informed consent prior to participation in the study
- Have a current diagnosis of Type I or Type II Diabetes Mellitus
- Have an Ankle-Arm Index between 0.35 and 0.8 on the study limb
- Be in reasonable metabolic control, exhibited by HbA1C values of less than12% as observed by serum test results obtained within 3 months prior to the Screening Visit
- Subject and caregiver must be accessible for, and willing to comply with, the safety procedures and available for the 12 week Follow-Up Period
You may not qualify if:
- Clinical evidence of gangrene on any part of affected foot
- Active Charcot's foot on the study limb
- Scheduled to undergo vascular surgery, angioplasty, or thrombolysis within 30 days from the end of the study
- Malnourished as evidenced by a pre-albumin of \< 11 mg/dL
- Pregnancy or lactating
- History of bleeding disorder
- Participation in another device study for the treatment of Peripheral Vascular Disease 30 days prior to Screening Visit
- Vascular procedures performed 30 days prior to Screening Visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York College of Podiatric Medicine
New York, New York, 10035, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Eileen Chusid, PHD
New York College of Podiatric Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDIV
Study Record Dates
First Submitted
September 29, 2007
First Posted
October 2, 2007
Study Start
October 1, 2007
Study Completion
November 1, 2007
Last Updated
March 4, 2008
Record last verified: 2008-03